CL Stock Analysis — Colgate-Palmolive
Sector: Consumer staples
AI Verdict
Colgate-Palmolive trades at 23.2x forward earnings for 58.2% expected EPS growth—cheap for a consumer staple if its brand moat delivers, but any stumble puts the premium at risk.
Competitive Moat
Colgate-Palmolive dominates oral care globally with entrenched brands and shelf space that create high switching costs for retailers and consumers. Its distribution muscle and brand equity make it hard for new entrants to dislodge its products from prime retail placement.
Summary
A sharp 58.2% jump in forward EPS growth is set to reset Colgate-Palmolive’s valuation story.
Where It Stands
Colgate-Palmolive has returned 9.78% over the past year, trades at 23.2x next year's earnings (just above the sector median of 20x), and sits at a neutral RSI of 59.2.
Key Metrics
- RSI: 59.2 — Neutral
- Trailing P/E: 36.8x
- Forward P/E: 23.2x
- PEG Ratio: 0.64
- Earnings Growth: +0.6%
- Revenue Growth: +0.1%
- Market Cap: $74.1B
- Dividend Yield: 0.02%
- 1-Year Return: 9.78%
- 52-Week High: $99.33
- 52-Week Low: $74.55
Analyst Consensus
20 Buy · 10 Hold · 1 Sell (31 analysts)
Bull Case
With analysts expecting 58.2% EPS growth and a forward P/E of 23.2x, you’re paying a fair price for a rare earnings surge in a defensive sector.
Bear Case
If the forward P/E reverts to the sector median of 20x, the stock would face a roughly 14% valuation drop from current levels.
Catalyst to Watch
Watch for quarterly earnings to confirm whether the 58.2% EPS growth is materializing, as any miss could trigger a swift P/E reset.